Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/09/trlv-stock-slides-as-bears-test-key-support-levels.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

TRLV Stock Slides As Bears Test Key Support Levels

TIM BOHEN•UPDATED SEP. 30, 2026, 12:34 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Trulieve Cannabis Corp. Subordinate stocks have been trading down by -15.03 percent amid intensifying regulatory and legalization uncertainty.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading TRLV

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • TRLV has broken down from the $12.50 area to near $10.50, putting recent momentum under pressure.
  • Daily chart shows lower highs forming, while intraday trading action is grinding sideways after the morning selloff.
  • Trulieve Cannabis Corp. Subordinate still posts strong gross margins near 60%, but bottom-line losses remain heavy.
  • Cash of roughly $325M and manageable debt give TRLV room to operate despite negative earnings.
  • Traders are watching whether $10–$10.50 holds or opens the door to a deeper pullback.

Candlestick Chart

Live Update At 12:34:19 EDT: On Wednesday, September 30, 2026 Trulieve Cannabis Corp. Subordinate stock [NYSE: TRLV] is trending down by -15.03%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

TRLV, the ticker for Trulieve Cannabis Corp. Subordinate, is trading like a name caught between solid revenue scale and ugly net losses. Over the last few days, TRLV slid from the mid-$12s to around $10.57, a sharp pullback that tells traders sentiment has cooled fast. That drop matters because it comes after a stretch of grinding gains, turning what looked like a steady uptrend into a possible short-term downtrend.

On the fundamentals, TRLV generated about $1.18B in revenue over the last year, with a gross margin near 59.5%. That means the core business still produces solid dollars after direct costs. But the company reported a quarterly net loss of roughly $406M, with profit margins deeply negative. Return on equity and assets are also in the red, which signals that TRLV is not yet turning its size into real profitability.

More Breaking News

The balance sheet is a bit cleaner. TRLV holds about $325M in cash, current ratio near 5.9, and total debt-to-equity around 0.75. That gives the company breathing room, but traders know the clock is always ticking when losses are this steep.

Why Traders Are Watching TRLV Price Action

TRLV has turned into a live case study in how sentiment can flip. Just a few sessions ago, TRLV was trading around $12.50, with buyers in control and dips getting scooped. The latest daily candles tell a different story. After topping near $12.93 earlier in the month, the stock is now printing lower highs and lower lows. That is classic trend deterioration, the kind experienced traders in the Tim Sykes community look for when stalking both short and bounce setups.

Look closer at the intraday tape. TRLV opened around $10.86, spiked quickly to $11.17, and then sold off into the low $10s. Since then, the 5‑minute chart shows choppy, sideways trading between roughly $10.30 and $10.60. That is a textbook intraday consolidation after a morning flush — volume fades, range tightens, and both bulls and bears catch their breath. For traders, that type of action usually sets up the next directional move.

The bigger backdrop adds tension. Trulieve Cannabis Corp. Subordinate has strong gross margins but keeps posting large net losses, including a recent quarterly loss north of $400M. TRLV also logged significant non-cash and restructuring-type items, which complicate the read for newer traders. Still, cash on hand and a moderate leverage profile keep a full-blown balance-sheet crisis off the table for now.

So traders are left to trade what’s in front of them: a stock that has sold off hard, is sitting near short-term support, and trades with enough volatility to offer clean risk-reward if you respect your stops.

Conclusion

TRLV is at one of those spots on the chart where discipline pays. Trulieve Cannabis Corp. Subordinate has pulled back more than $1.80 from recent highs, and the daily trend has weakened. Yet the company still throws off over $1B in annual revenue, with a strong gross margin and a balance sheet that shows meaningful cash and manageable debt. That mix — real scale, big losses, and active price swings — is exactly why traders keep TRLV on their watchlists.

From here, the key is simple. If TRLV holds the $10–$10.50 zone and starts to curl back up, short-term bounce traders may look for a push toward prior resistance in the $11.50–$12 area. If that support fails on heavy volume, momentum traders will treat it as a potential breakdown and plan accordingly. No predictions — just levels, risk, and reaction. As Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” That mindset lines up with this kind of setup — focus on the price action in front of you and let the chart confirm or deny the thesis in real time.

As Tim Sykes loves to remind traders, “The market doesn’t care about your opinion, only your plan and your discipline.” TRLV is giving plenty of data right now — from the bleeding income statement to the tightening intraday range. The edge goes to traders who study the charts, understand the financial reality behind Trulieve Cannabis Corp. Subordinate, and react to price action instead of guessing the future. This is educational material, not advice — use it to sharpen your process, not to blindly follow a trade.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders